Melissa L. Jampol, a Member of the Firm in the Health Care and Life Sciences and Litigation practices, in the firm’s New York office, and Matthew Savage Aibel, an Associate in the Litigation and Employment, Labor & Workforce Management practices, in the firm’s New York office, co-authored an article in The FCPA Blog, titled “DOJ Targets Healthcare with FCPA Enforcement.”
Following is an excerpt:
The acting chief of the DOJ’s Criminal Fraud Section announced a new partnership last month between the DOJ’s Healthcare Fraud Unit’s Corporate Strike Force and Foreign Corrupt Practices Act prosecutors.
Their mission is to “investigate and prosecute matters relating to health care bribery schemes, both domestic and abroad.”
Sandra Moser, speaking at the ACI Global Forum on Anti-Corruption in High Risk Matters on July 25, said the new partnership formalized the coordination of healthcare bribery cases within DOJ.
Moser’s announcement is an affirmation that DOJ’s focus on international and domestic healthcare fraud is not subject to political tailwinds. Her words signal that while there was a slowdown in both healthcare fraud and FCPA cases brought by Main Justice in the first half of 2017, the DOJ is stepping up its enforcement efforts.